Assessment of potential doubling time (T(pot)), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma

Experimental Hematology

Volumn 24, Issue 7, 1996, Pages 807-815

  Vail, D M ^a   Kisseberth, W C ^a   Obradovich, J E ^a   Moore, F M ^a   London, C A ^a   MacEwen, E G ^a   Ritter, M A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

AgNOR; Bromodeoxyuridine; Canine; Non Hodgkin's lymphoma; PCNA; Proliferation; T(pot)

Indexed keywords

BROXURIDINE; CYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME NOR; CONTROLLED STUDY; DOG; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS;

ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; DOXORUBICIN; FEMALE; LIFE TABLES; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; NUCLEOLUS ORGANIZER REGION; PREDICTIVE VALUE OF TESTS; PREDNISONE; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; REMISSION INDUCTION; SILVER STAINING; TREATMENT OUTCOME; TUMOR STEM CELLS; VINCRISTINE;

EID: 0029682656     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)